Publication:
Cardiovascular effects of CDP-choline and its metabolites: Involvement of peripheral autonomic nervous system

dc.contributor.buuauthorCansev, Mehmet
dc.contributor.buuauthorYılmaz, Mustafa Serdar
dc.contributor.buuauthorİlçöl, Yeşim Özarda
dc.contributor.buuauthorHamurtekin, Emre
dc.contributor.buuauthorUlus, İsmil Hakkı
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentFarmakoloji ve Klinik Farmakoloji Ana Bilim Dalı
dc.contributor.departmentBiyokimya Ana Bilim Dalı
dc.contributor.orcid0000-0003-2918-5064
dc.contributor.orcid0000-0001-9496-1475
dc.contributor.researcheridAAH-1571-2021
dc.contributor.researcheridD-5340-2015
dc.contributor.researcheridM-9071-2019
dc.contributor.researcheridAAL-8873-2021
dc.contributor.scopusid8872816100
dc.contributor.scopusid8895544100
dc.contributor.scopusid35741320500
dc.contributor.scopusid8717648500
dc.contributor.scopusid7004271086
dc.date.accessioned2022-09-12T08:45:12Z
dc.date.available2022-09-12T08:45:12Z
dc.date.issued2007-12-22
dc.description.abstractIntraperitoneal administration of CDP-choline (200-900 mu mol/kg) increased blood pressure and decreased heart rate of rats in a dose- and time-dependent manner. These responses were accompanied by elevated serum concentrations of CDP-choline and its metabolites phosphocholine, choline, cytidine monophosphate and cytidine. Blood pressure increased by intraperitoneal phosphocholine (200-900 mu mol/ kg), while it decreased by choline (200-600 mu mol/kg) administration; phosphocholine or choline administration (up to 600 mu mol/kg) decreased heart rate. Intraperitoneal cytidine monophosphate (200-600 mu mol/kg) or cytidine (200-600 mu mol/kg) increased blood pressure without affecting heart rate. Pressor responses to CDP-choline, phosphocholine, cytidine monophosphate or cytidine were not altered by pretreatment with atropine methyl nitrate or hexamethonium while hypotensive effect of choline was reversed to pressor effect by these pretreatments. Pretreatment with atropine plus hexamethonium attenuated or blocked pressor response to CDP-choline or phosphocholine, respectively. Heart rate responses to CDP-choline, phospbocholine and choline were blocked by atropine and reversed by hexamethonium. Cardiovascular responses to CDP-choline, phosphocholine and choline, but not cytidine monophosphate or cytidine, were associated with elevated plasma catecholamines concentrations. Blockade of alpha-adrenoceptors by prazosin or yohimbine attenuated pressor response to CDP-choline while these antagonists blocked pressor responses to phosphocholine or choline. Neither bilateral adrenalectomy nor chemical sympathectomy altered cardiovascular responses to CDPcholine, choline, cytidine monophosphate or cytidine. Sympathectomy attenuated pressor response to phosphocholine. Results show that intraperitoneal administration of CDP-choline and its metabolites alter cardiovascular parameters and suggest that peripheral cholinergic and adrenergic receptors are involved in these responses.
dc.identifier.citationCansev, M. vd. (2007). "Cardiovascular effects of CDP-choline and its metabolites: Involvement of peripheral autonomic nervous system". European Journal of Pharmacology, 577(1-3), 129-142.
dc.identifier.endpage142
dc.identifier.issn0014-2999
dc.identifier.issn1879-0712
dc.identifier.issue1-3
dc.identifier.pubmed17884041
dc.identifier.scopus2-s2.0-35449003300
dc.identifier.startpage129
dc.identifier.urihttps://doi.org/10.1016/j.ejphar.2007.08.029
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0014299907009417
dc.identifier.urihttp://hdl.handle.net/11452/28641
dc.identifier.volume577
dc.identifier.wos000251155000018
dc.indexed.scopusScopus
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherElsevier Science
dc.relation.journalEuropean Journal of Pharmacology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectCardiovascular
dc.subjectReverses hypotension
dc.subjectMuscarinic receptors
dc.subjectBlood-pressure
dc.subjectAcetylcholine
dc.subjectRelease
dc.subjectRat
dc.subjectstroke
dc.subjectCiticoline
dc.subjectMice
dc.subjectDog
dc.subjectCDP-choline
dc.subjectCholine
dc.subjectCytidine
dc.subjectPhosphocholine
dc.subject.emtreeYohimbine
dc.subject.emtreeAtropine
dc.subject.emtreeCatecholamine
dc.subject.emtreeCholine
dc.subject.emtreeCiticoline
dc.subject.emtreeCytidine
dc.subject.emtreeCytidine phosphate
dc.subject.emtreeDexamethasone
dc.subject.emtreeHexamethonium
dc.subject.emtreePhosphorylcholine
dc.subject.emtreePrazosin
dc.subject.emtreePropranolol
dc.subject.emtreeVasopressin
dc.subject.emtreeDrug antagonism
dc.subject.emtreeAdrenalectomy
dc.subject.emtreeAnimal experiment
dc.subject.emtreeAnimal model
dc.subject.emtreeArticle
dc.subject.emtreeAutonomic nervous system
dc.subject.emtreeBlood pressure
dc.subject.emtreeCardiovascular effect
dc.subject.emtreeCatecholamine blood level
dc.subject.emtreeControlled study
dc.subject.emtreeMale
dc.subject.emtreeRug antagonism
dc.subject.emtreeDrug blood level
dc.subject.emtreeHeart rate
dc.subject.emtreeHypotension
dc.subject.emtreeNonhuman
dc.subject.emtreeVasopressin blood level
dc.subject.emtreePlasma renin activity
dc.subject.emtreePriority journal
dc.subject.emtreeRat
dc.subject.emtreeSympathectomy
dc.subject.meshCatecholamines
dc.subject.meshAdrenal glands
dc.subject.meshAdrenalectomy
dc.subject.meshAnimals
dc.subject.meshAorta, thoracic
dc.subject.meshAutonomic nervous system
dc.subject.meshBlood pressure
dc.subject.meshHeart rate
dc.subject.meshCholine
dc.subject.meshCytidine
dc.subject.meshCytidine diphosphate choline
dc.subject.meshCytidine monophosphate
dc.subject.meshHeart atria
dc.subject.meshPhosphorylcholine
dc.subject.meshMale
dc.subject.meshNootropic agents
dc.subject.meshParasympathetic nervous system
dc.subject.meshPeripheral nerves
dc.subject.meshRats
dc.subject.meshRats, wistar
dc.subject.meshRenin
dc.subject.meshSympathectomy, chemical
dc.subject.meshVasopressins
dc.subject.scopusCiticoline; Neuroprotective Agents; Glycerylphosphorylcholine
dc.subject.wosPharmacology & pharmacy
dc.titleCardiovascular effects of CDP-choline and its metabolites: Involvement of peripheral autonomic nervous system
dc.typeArticle
dc.wos.quartileQ2
dc.wos.quartileQ2
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Farmakoloji ve Klinik Farmakoloji Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Biyokimya Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atWOS
local.indexed.atScopus

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: